Inhibition of Rat Splenocyte Proliferation with Methylprednisolone: In Vivo Effect of Liposomal Formulation
- 1 January 1994
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 11 (6) , 848-854
- https://doi.org/10.1023/a:1018929824798
Abstract
The effect of a liposomal formulation of methylprednisolone (MPL) on the inhibition of lymphocyte proliferation in spleen cells was investigated following IV dosing in rats. Liposomes do not alter...Keywords
This publication has 28 references indexed in Scilit:
- Conceptualization of drug distribution to a hypothetical pharmacodynamic effect compartmentClinical Pharmacology & Therapeutics, 1993
- Enhancement of Tissue Delivery and Receptor Occupancy of Methylprednisolone in Rats by a Liposomal FormulationPharmaceutical Research, 1993
- Pharmacoimmunodynamics of methylprednisolone: Trafficking of helper T lymphocytesJournal of Pharmacokinetics and Biopharmaceutics, 1992
- The role of the spleen in lymphocyte migration.1991
- Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individualsClinical Immunology and Immunopathology, 1990
- Inhibition of PHA lymphocyte responses by cyclosporine and methylprednisolone.1990
- Pharmacokinetics of two Alternative Dosage Forms for Cyclosporine: Liposomes and IntralipidJournal of Pharmaceutical Sciences, 1990
- EVIDENCE THAT GLUCOCORTICOSTEROIDS BLOCK EXPRESSION OF THE HUMAN INTERLEUKIN-6 GENE BY ACCESSORY CELLSTransplantation, 1990
- Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjectsClinical Pharmacology & Therapeutics, 1989
- Second generation model for prednisolone pharmacodynamics in the ratJournal of Pharmacokinetics and Biopharmaceutics, 1989